» Articles » PMID: 15152009

Expression of a Dominant Negative Heat Shock Factor-1 Construct Inhibits Aneuploidy in Prostate Carcinoma Cells

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2004 May 21
PMID 15152009
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Recent studies have implicated heat shock proteins (HSP) and heat shock transcription factor 1 (HSF1) in tumor progression. We have examined the role of HSF1 in the malignant phenotype of PC-3 prostate carcinoma cells. We have developed a dominant negative construct of HSF1 that antagonizes transcription from HSP promoters and results in the depletion of intracellular HSP 70. Our studies indicate that expression of DN-HSF1 dramatically alters the DNA content of PC-3 cells (derived from p53 null prostatic carcinoma) and inhibits aneuploidy in these cells. This effect is due to prolonged expression of DN-HSF1, and transient expression of the dominant negative factor from an inducible promoter failed to cause the effect. Inhibition of aneuploidy in p53 null PC-3 cells by DN-HSF1 expression was recapitulated by expression within the cells of wild type p53. Furthermore, cells expressing DN-HSF1 showed a profound inhibition in the development of aneuploidy when exposed to chemical agents that disrupt the mitotic spindle and prevent progression through metaphase. Inhibition of aneuploidy in PC-3 cells expressing DN-HSF1 was associated with delayed breakdown of cyclin B1 compared with controls, consistent with a role for wild type HSF1 in the regulation of cyclin B1 degradation, a key step in the control of mitosis. Our experiments therefore demonstrate that HSF1 plays a functional role in cancer cells under nonstress conditions and influences cell cycle behavior and progression through mitosis and promotes the development of the aneuploid state.

Citing Articles

HSF1 is a prognostic determinant and therapeutic target in intrahepatic cholangiocarcinoma.

Cigliano A, Gigante I, Serra M, Vidili G, Simile M, Steinmann S J Exp Clin Cancer Res. 2024; 43(1):253.

PMID: 39243039 PMC: 11378393. DOI: 10.1186/s13046-024-03177-7.


The Interplay between Heat Shock Proteins and Cancer Pathogenesis: A Novel Strategy for Cancer Therapeutics.

Somu P, Mohanty S, Basavegowda N, Yadav A, Paul S, Baek K Cancers (Basel). 2024; 16(3).

PMID: 38339390 PMC: 10854888. DOI: 10.3390/cancers16030638.


Heat Shock Transcription Factor 2 Is Significantly Involved in Neurodegenerative Diseases, Inflammatory Bowel Disease, Cancer, Male Infertility, and Fetal Alcohol Spectrum Disorder: The Novel Mechanisms of Several Severe Diseases.

Tokunaga Y, Otsuyama K, Kakuta S, Hayashida N Int J Mol Sci. 2022; 23(22).

PMID: 36430241 PMC: 9691173. DOI: 10.3390/ijms232213763.


Inhibition of Heat Shock Factor 1 Signaling Decreases Hepatoblastoma Growth via Induction of Apoptosis.

Hurley E, Tao J, Liu S, Krutsenko Y, Singh S, Monga S Am J Pathol. 2022; 193(2):148-160.

PMID: 36336065 PMC: 9887635. DOI: 10.1016/j.ajpath.2022.10.006.


Cell Cycle Regulation by Heat Shock Transcription Factors.

Tokunaga Y, Otsuyama K, Hayashida N Cells. 2022; 11(2).

PMID: 35053319 PMC: 8773920. DOI: 10.3390/cells11020203.